Loading clinical trials...
Loading clinical trials...
This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sunnybrook Health Sciences Centre
Collaborators
NCT04838301 · Alzheimer Dementia, Late Onset Alzheimer Disease, and more
NCT07467460 · PARKINSON DISEASE (Disorder), Alzheimer s Disease, and more
NCT07234695 · Down Syndrome, Down Syndrome (DS), and more
NCT07262645 · Alzheimer s Disease
NCT07222280 · Alzheimer Dementia, Alzheimer Disease, and more
Sunnybrook Research Institute
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions